Preoxygenated hyperventilated hypocapnic apnea-induced radiation (PHAIR) in breast cancer patients

Radiother Oncol. 2011 Aug;100(2):231-5. doi: 10.1016/j.radonc.2011.02.017. Epub 2011 Apr 16.

Abstract

Introduction: The study was performed to quantify the benefit of preoxygenated hyperventilated hypocapnic apnea-induced radiation (PHAIR) for breath hold (BH) time in patients with breast cancer.

Methods and materials: We compared in a single blind study 6 healthy volunteers and 10 breast cancer patients using PHAIR. Both groups were subdivided into two arms, each including 4min eupnea and hyperventilation with 20 breaths/min to 19-20mmHG FeCO2 before apnea without (hBH) and with 100% oxygen (ohBH). Apnea times were measured with an in-house breathholding device and an adapted ventilator, and blood and respiration gas parameters through our laboratory.

Results: The experiment was well-tolerated by patients without compromising their security. A significant increase in BH was observed upon hBH and ohBH compared to standard breath hold - up to 700% in ohBH. There is evidence that the patients interrupted their breath hold before the actual physiological end.

Conclusion: PHAIR is a feasible, safe and recommendable technique that could be used to improve BH for high precision radiotherapy. Further research is necessary to obtain a clinical value for this technique.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Apnea / physiopathology
  • Breast Neoplasms / radiotherapy*
  • Female
  • Humans
  • Hyperventilation / physiopathology
  • Hypocapnia / physiopathology
  • Middle Aged
  • Oxygen / administration & dosage*
  • Radiotherapy, Intensity-Modulated / methods*
  • Reactive Oxygen Species / metabolism
  • Respiration*
  • Single-Blind Method
  • Time Factors

Substances

  • Reactive Oxygen Species
  • Oxygen